From: Trimodality bladder-sparing approach without neoadjuvant chemotherapy for node-negative localized muscle-invasive urinary bladder cancer resulted in comparable cystectomy-free survival
Evaluable patients (n = 64)
Complete response (CR)
50 (78.1%)
Partial response (PR)
2 (3.1%)
Stable disease (SD)
3 (4.7%)
Progressive disease (PD)
9 (14.1%)